Target intelligence / Profile preview

Bacterial enzymes and ribosomes

Molecular classification
Enzyme, Ribonucleoprotein complex, RNA-binding protein
01

Overview

Bacterial enzymes and ribosomes represent a diverse set of essential biological targets found in prokaryotic organisms that are fundamental for their survival, growth, and reproduction. The bacterial ribosome (70S), composed of the 30S and 50S subunits, is the site of protein synthesis and is a primary target for several classes of antibiotics that exploit its structural differences from the eukaryotic 80S ribosome to achieve selective toxicity. Concurrently, bacterial enzymes such as DNA gyrase, RNA polymerase, and penicillin-binding proteins facilitate critical processes including DNA supercoiling, transcription, and peptidoglycan layer assembly. Drugs targeting these components—collectively known as antibiotics—interrupt these vital pathways to treat bacterial infections. However, the efficacy of targeting these molecules is increasingly compromised by the development of resistance mechanisms, such as target modification, enzymatic inactivation, and efflux pumps, which remain a significant challenge in clinical medicine.

Other names
Prokaryotic translational machineryBacterial metabolic enzymes70S ribosomeProkaryotic enzymes
02

Mechanism of action

Inhibition of the 30S or 50S ribosomal subunits to block translation; inhibition of DNA gyrase or topoisomerase IV to prevent DNA replication; inhibition of penicillin-binding proteins to disrupt cell wall synthesis; inhibition of dihydropteroate synthase to block folate metabolism.

03

Biological functions

Protein synthesisCell wall biosynthesisDNA replicationRNA transcriptionFolic acid synthesisMetabolic catalysis
04

Disease associations

Infection
05

Safety considerations

Antimicrobial resistance (AMR)Disruption of the human microbiome (dysbiosis)Hypersensitivity and allergic reactionsDrug-specific toxicities (e.g., ototoxicity and nephrotoxicity with aminoglycosides)Superinfections (e.g., Clostridioides difficile)
06

Interacting drugs

Amoxicillin

8 more in the full profile.

07

Biomarkers

Minimum inhibitory concentration (MIC)Bacterial load (CFU/mL)Procalcitonin levelsC-reactive protein (CRP)Presence of antibiotic resistance genes (e.g., mecA, blaTEM)

Beyond the preview

Go deeper on Bacterial enzymes and ribosomes.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Bacterial enzymes and ribosomes.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call